Carthera
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $56M
Investors
- 8
About Carthera
Founded in 2010 and headquartered in Lyon, France, Carthera focuses on the development of ultrasound-based therapies for severe brain disorders. The company was established by Alexandre Carpentier, Delphine de La Ferrière-Carpentier, and Murielle Lemoine.Carthera specializes in developing innovative ultrasound-based medical devices designed to treat severe brain disorders, focusing primarily on glioblastoma, brain metastases, and neurodegenerative diseases such as Alzheimer's Disease. The cornerstone of their product offerings is the SonoCloud® device, which utilizes low-intensity pulsed ultrasound (LIPU) to temporarily increase the permeability of the blood-brain barrier (BBB). This unique approach allows for enhanced delivery of chemotherapy and other therapeutic agents directly to the brain, significantly improving the potential efficacy of these treatments. Released initially in clinical trials, SonoCloud® is designed to be used both before and after the injection of drugs, with investigations ongoing into its applications across various brain-related conditions.10, with an EBITDA of EUR -7,526,222. The company generates revenue through partnerships and collaborations with pharmaceutical companies and healthcare institutions, focusing on the commercialization of its flagship device, SonoCloud®. The company plans to further develop its SonoCloud® technology and explore new products aimed at enhancing treatment for severe brain conditions.
Who invested in Carthera
8 investors across 3 rounds
See all investors in Carthera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Carthera
Who invested in Carthera?
Carthera has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Carthera raised?
Carthera has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Carthera last raise money?
Carthera's most recent round on record is a Series B, in Dec 2023.
What does Carthera do?
Founded in 2010 and headquartered in Lyon, France, Carthera focuses on the development of ultrasound-based therapies for severe brain disorders.
Where is Carthera headquartered?
Carthera is headquartered in Lyon, France.
Which VCs invest in companies like Carthera?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Carthera's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Carthera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.